Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.67
+0.15 (1.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $697.47 million as of December 20, 2024. Its market cap has increased by 116.77% in one year.
Market Cap
697.47M
Enterprise Value
1.06B
1-Year Change
116.77%
Ranking
Category
Stock Price
$10.67
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $697.47M, a decrease of -2.24%. That is a compound annual growth rate of -0.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 697.47M | 110.19% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 716.40M |
| Avanos Medical | 713.88M |
| Oculis Holding AG | 712.23M |
| Ironwood Pharmaceuticals | 712.13M |
| Kura Oncology | 704.40M |
| Tectonic Therapeutic | 697.06M |
| Evolus | 694.64M |
| Keros Therapeutics | 692.88M |